BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Not So Fast Emerging Markets: Results From KMR Group's Site Contracts Study


11/15/2012 10:57:39 AM

CHICAGO, Illinois, November 14, 2012 – KMR Group, a leader in analyzing R&D performance data for the biopharmaceutical R&D industry, recently concluded an assessment of Industry site contract cycle times. This is the third study of site contract cycle times by KMR since 2006; this round also incorporated global contracts. Almost 9000 recently-executed contracts from leading biopharmaceutical companies were analyzed.

North America has the overall shortest contract cycle times with a median 1.3 months and performs the best by a significant margin. At the opposite end of the spectrum, emerging market regions take 3 to 4 times longer than North America. For example Brazil, India and Taiwan all have median cycle times of over 5 months. Although there is high interest to conduct studies in low cost emerging market regions, the delay in these cycle times is a factor to be considered in trial planning.

The study examined site contract performance in many ways, comparing study phase, type of site (independent, institution), therapy area, region and country level performance, and use of master agreements. Regulatory document completion times were also assessed. The survey not only showed each company how its performance ranked against other major companies in the Industry, it also provided context on more qualitative site contracting practices such as payment strategies, timing, and terms.

“This study gives participants reliable benchmarks and detailed company performance information that can be directly incorporated into site contracting strategies. This type of information is invaluable for setting timelines, which translates into faster study start-up. We are encouraged that each time we run this study there are new insights which are used to improve our clients’ performance,” commented Linda Martin, Principal of KMR Group.

For further information on future rounds of the Site Contracts Study contact:

Linda Martin, Principal Tel: +1 (312) 795-0400 Email: lmartin@kmrgroup.com

About KMR

KMR Group has worked exclusively in the biopharmaceutical R&D industry since the early 1990s. We are industry leaders in benchmarking, analytics and performance management as well as development of on-line analytics tools that give users access to confidential and rich datasets. KMR's clinical platform contains the most reliable source for trial performance, recruitment and site metrics data, with over 15,000 global clinical trials. Clients rely on these tools for trial, enrollment and investigator site benchmarks to help them define recruitment strategies, shape enrollment plans and forecast recruitment as well as to find untried sites and select the best performing sites. These tools and analyses help companies make better decisions so that they can get their products to market faster and more effectively. For more information or for a demonstration of any of KMR's tools, please contact us.

Visit our website at https://kmrgroup.com



Read at BioSpace.com

KMR Group
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES